Background
The rarity of metaplastic breast carcinoma (MBC) has resulted in limited sonographic data. Given the inferior prognosis of MBC compared to invasive ductal carcinoma (IDC), accurate preoperative differentiation between the two is imperative for effective treatment planning and prognostic prediction. The objective of this study was to assess the diagnostic accuracy of MBC and differentiate it from IDC by analyzing sonographic and clinicopathologic features.
Methods
In this retrospective cohort study, 197 women comprising 200 IDC lesions were enrolled between January 2012 and December 2021 and 20 women comprising 20 pure MBC lesions were enrolled between January 2019 and December 2019. A comparison was made between the sonographic and clinicopathologic characteristics of MBC and IDC.
Results
The results indicated that patients with MBC had a higher proportion of tumor grade 3 (95.0%
vs.
32.5%; P<0.001), high Ki-67 expression (100.0%
vs.
75.0%; P<0.001), and the triple-negative subtype (90.0%
vs.
13.0%; P<0.001) as compared to those with IDC. On ultrasound (US) findings, MBC lesions tended to have a larger size (≥5 cm: 45.0%
vs.
1.5%; P<0.001), regular shape (45.0%
vs.
1.5%, P<0.001), circumscribed margin (40.0%
vs.
0.5%, P<0.001), a complex cystic and solid echo pattern (50.0%
vs.
3.5%; P<0.001), and posterior acoustic enhancement (95.0%
vs.
14.5%; P<0.001). Additionally, MBC was more likely to be misinterpreted as a benign lesion by sonographers than was IDC (30.0%
vs.
4.5%; P<0.001). Multilayer perceptron analysis revealed posterior acoustic enhancement, circumscribed margins, and size as distinguishing factors between these two tumor types. The estimated rates of local recurrence, distant metastasis, and 5-year overall survival in 19 cases with MBC were found to be 10.5%, 31.6%, and 65.0%, respectively.
Conclusions
MBC typically presents as a large breast mass with more benign US features in older women, findings which may facilitate its accurate diagnosis and differentiation from other breast masses.